A phase 2 study of LY3023414 and necitumumab after first-line chemotherapy for metastatic squamous non-small cell lung cancer (NSCLC)M. Johnson,V. Wacheck, M. Hussein,M. McCleod,D. Daniel,David Waterhouse,M. Gil,D. Strickland,Johanna C. BendellANNALS OF ONCOLOGY(2016)引用 2|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要